ResearcherUniversidade Federal de PernambucoActive in the last 2 years

Lília Vieira Galdino

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3776-7531; OpenAlex author ID A5034708643. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper

Papers 2

5-nitro-thiophene-thiosemicarbazone derivative induces cell death, cell cycle arrest, and phospho-kinase shutdown in pancreatic ductal adenocarcinoma cells. Co-author DOI 10.1016/j.ejphar.2024.176963 ↗
Galectin-12 in Pancreatic Cancer: A New Player in the Microenvironment? Co-author DOI 10.1097/mpa.0000000000001909 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Amanda P.B. Albuquerque · 2 shared papers, 2021–2024 · strength 0.37
- Paper 5-nitro-thiophene-thiosemicarbazone derivative induces cell death, cell cycle arrest, and phospho-kinase shutdown in pa… DOI 10.1016/j.ejphar.2024.176963 ↗
- Paper Galectin-12 in Pancreatic Cancer: A New Player in the Microenvironment? DOI 10.1097/mpa.0000000000001909 ↗
Moacyr Jesus Barreto de Melo Rêgo · 2 shared papers, 2021–2024 · strength 0.37
- Paper 5-nitro-thiophene-thiosemicarbazone derivative induces cell death, cell cycle arrest, and phospho-kinase shutdown in pa… DOI 10.1016/j.ejphar.2024.176963 ↗
- Paper Galectin-12 in Pancreatic Cancer: A New Player in the Microenvironment? DOI 10.1097/mpa.0000000000001909 ↗
Michelle Melgarejo da Rosa · 1 shared paper, 2024 · strength 0.21
- Paper 5-nitro-thiophene-thiosemicarbazone derivative induces cell death, cell cycle arrest, and phospho-kinase shutdown in pa… DOI 10.1016/j.ejphar.2024.176963 ↗
Valécia de Cássia Mendonça da Costa · 1 shared paper, 2024 · strength 0.21
- Paper 5-nitro-thiophene-thiosemicarbazone derivative induces cell death, cell cycle arrest, and phospho-kinase shutdown in pa… DOI 10.1016/j.ejphar.2024.176963 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.